KLSE (MYR): TMCLIFE (0101)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.60
Today's Change
+0.01 (1.69%)
Day's Change
0.595 - 0.605
Trading Volume
751,700
Market Cap
1,045 Million
NOSH
1,742 Million
Latest Quarter
31-Mar-2023 [#3]
Announcement Date
23-May-2023
Next Quarter
30-Jun-2023
Est. Ann. Date
23-Aug-2023
Est. Ann. Due Date
29-Aug-2023
QoQ | YoY
160.36% | 105.11%
Revenue | NP to SH
297,587.000 | 49,481.000
RPS | P/RPS
17.08 Cent | 3.51
EPS | P/E | EY
2.84 Cent | 21.12 | 4.73%
DPS | DY | Payout %
0.28 Cent | 0.47% | 9.86%
NAPS | P/NAPS
0.49 | 1.22
QoQ | YoY
17.38% | 128.31%
NP Margin | ROE
16.63% | 5.80%
F.Y. | Ann. Date
31-Mar-2023 | 23-May-2023
Latest Audited Result
30-Jun-2022
Announcement Date
05-Oct-2022
Next Audited Result
30-Jun-2023
Est. Ann. Date
05-Oct-2023
Est. Ann. Due Date
27-Dec-2023
Revenue | NP to SH
243,774.000 | 41,389.000
RPS | P/RPS
13.99 Cent | 4.29
EPS | P/E | EY
2.38 Cent | 25.25 | 3.96%
DPS | DY | Payout %
0.28 Cent | 0.47% | 11.78%
NAPS | P/NAPS
0.47 | 1.28
YoY
104.35%
NP Margin | ROE
16.98% | 5.06%
F.Y. | Ann. Date
30-Jun-2022 | 23-Aug-2022
Revenue | NP to SH
302,388.000 | 34,682.666
RPS | P/RPS
17.36 Cent | 3.46
EPS | P/E | EY
1.99 Cent | 30.13 | 3.32%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
47.99% | 45.16%
NP Margin | ROE
11.47% | 4.06%
F.Y. | Ann. Date
31-Mar-2023 | 23-May-2023
Trailing 4 Quarters | Trailing 8 Quarters | |||
---|---|---|---|---|
Available Quarters | 4 Quarters | 8 Quarters | ||
Continuous Quarters Of Revenue Growth | 4 / 4 | 100.00% | 6 / 8 | 75.00% |
Total Positive Profit Years | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
Continuous Quarters Of Positive Profit | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
Continuous Quarters Of Profit Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
Continuous Quarters Of Adjusted EPS Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
Total Dividend Years | 1 / 4 | 25.00% | 2 / 8 | 25.00% |
Continuous Quarters Of Dividend | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Dividend Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Adjusted Dps Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Average ROE | 1.49% | 1.08% | ||
Average Net Profit Margin | 16.71% | 13.08% |
Last 5 Financial Years | Last 10 Financial Years | |||
---|---|---|---|---|
Available Years | 5 Years | 10 Years | ||
Continuous Quarters Of Revenue Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
Total Positive Profit Years | 4 / 5 | 80.00% | 9 / 10 | 90.00% |
Continuous Quarters Of Positive Profit | 4 / 5 | 80.00% | 4 / 10 | 40.00% |
Continuous Quarters Of Profit Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
Continuous Quarters Of Adjusted EPS Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
Total Dividend Years | 4 / 5 | 80.00% | 9 / 10 | 90.00% |
Continuous Quarters Of Dividend | 4 / 5 | 80.00% | 4 / 10 | 40.00% |
Continuous Quarters Of Dividend Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
Continuous Quarters Of Adjusted Dps Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
Average ROE | 2.61% | 3.10% | ||
Average Net Profit Margin | 10.02% | 11.67% |
T4Q | Annualized | Annual (Unaudited) | Last 10 FY Average | Last 5 FY Average | |
---|---|---|---|---|---|
Revenue | 297,587 | 302,388 | 243,774 | 148,181 | 158,636 |
NP to SH | 49,481 | 34,682 | 41,389 | 19,771 | 20,602 |
Dividend | 4,877 | 0 | 4,877 | 2,669 | 3,029 |
Adjusted EPS | 2.84 | 1.99 | 2.38 | 1.13 | 1.18 |
Adjusted DPS | 0.28 | 0.00 | 0.28 | 0.15 | 0.17 |
NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share
All figures in '000 unless specified.
EPS & DPS's figures in Cent.
LQ QoQ | LQ YoY | CQ YoY | LQ vs Average of T4Q | LQ vs Average of T8Q | |
---|---|---|---|---|---|
Revenue | 11.23% | 33.56% | 31.11% | 9.66% | 24.56% |
NP to Owner | 160.36% | 105.11% | 45.16% | 15.55% | 60.71% |
Dividend | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Adjusted EPS | 156.25% | 105.00% | 44.66% | 15.09% | 60.00% |
Adjusted DPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year
T4Q vs LFY | T4Q vs AL5FY | T4Q vs AL10FY | AQR vs LFY | AQR vs AL5FY | AQR vs AL10FY | LFY YoY | LFY vs AL5FY | LFY vs AL10FY | |
---|---|---|---|---|---|---|---|---|---|
Revenue | 22.07% | 87.59% | 100.83% | 24.04% | 90.62% | 104.07% | 21.27% | 53.67% | 64.51% |
NP to Owner | 19.55% | 140.17% | 150.26% | -16.20% | 68.34% | 75.42% | 104.35% | 100.89% | 109.34% |
Dividend | 0.00% | 61.01% | 82.69% | 0.00% | 0.00% | 0.00% | 27.27% | 61.01% | 82.69% |
Adjusted EPS | 19.33% | 140.15% | 150.23% | -16.39% | 68.27% | 75.34% | 105.17% | 101.25% | 109.70% |
Adjusted DPS | 0.00% | 61.01% | 82.69% | 0.00% | 0.00% | 0.00% | 27.27% | 61.01% | 82.69% |
T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year
'On 5 July 2021, the newly completed building received Certificate of Completion and Compliance (“CCC”).
The expansion of THKD is on target to open by Q2 or Q3 of FY2022. In addition to specialist clinics and inpatient rooms, the new building will also house a brand-new Cancer & Theranostics Centre, Nuclear Medicine Centre, Eye Health Centre, Preventive Health and Family Medical Centre, amongst others.'
that is almost 9 months after getting CCC only open. usual time taken is about 3 months to get in the equipment and license from MoH
2021-10-06 21:23
I invest since year 2012. For me no entry point but invest regularly if possible. Long term investment. Trade at own risk ya ~.~
2021-11-23 15:40
results will be better and better only....with new wing opening, more bed capacity, more revenue and profit
2022-02-10 13:09
New wing started to contribute to the financial result. As time goes, significant improvement will show very soon.
2022-08-24 07:14
Myeye
~.~ +0.57 support support ~.~
2021-09-27 15:54